FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy
NCT05533983
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Solid Carcinoma
Interventions
OTHER:
fecal microbiota transplantation with Nivolumab
Sponsor
Asan Medical Center